Article Information
History
- November 28, 2021.
Article Versions
- Version 1 (November 21, 2021 - 09:19).
- You are currently viewing Version 2 of this article (November 28, 2021 - 17:04).
- View Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Hans C Ossebaard, PhD1,*,
- Pieter ten Have, MD2,
- Peter Th. W. van Hal, Medical Advisor, MD, PhD, MSc3,2,
- Iris Wichers, MD, PhD4,
- Johan Kooistra, MA5,
- Paul Hagedoorn6,
- Evelyn Brakema, MD7,
- Prof Niels Chavannes, PhD, MD7 and
- Pauline de Heer, MSc8
- 1National Health Care Institute, P.O. Box 320, 1110 AH, Diemen, The Netherlands
- 2Dutch National Health Care Institute, Diemen, The Netherlands
- 3Dept. of Respiratory Medicine, Van Weel - Bethesda Hospital, Dirksland, The Netherlands
- 4Dutch College of General Practitioners, Utrecht, The Netherlands
- 5BENU Pharmacies, Maarssen, The Netherlands
- 6Department of Pharmaceutical Technology and Biopharmacy, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands
- 7Public Health and Primary Care, Leiden University Medical Center, Leiden, The Netherlands
- 8National Health Care Institute, Diemen, The Netherlands
- ↵*Name/address corresponding author
Hans C Ossebaard PhD, hossebaard{at}zinl.nl
Posted November 28, 2021.
Turning green: the impact of changing to more eco-friendly respiratory healthcare. A carbon and cost analysis of Dutch prescription data
